Efficacy of low dose lung radiotherapy in the management of Covid-19 patients

Sri Venkateswara Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Age 40 years or more and 2. Patients confirmed to have COVID-19 based on a positive RT_PCR for SARS CoV-2 and have been admitted to the hospital and 3. patients with any of a. PaO2/FiO2 between 100mmHg and 300mmHg or b. Respiratory rate >24per min or more, breathlessness or c. SpO2 <94% on room air and 4. Lung parenchymal involvement at baseline CT scan

•1.Pregnancy and lactating mother
•2.Prior thoracic radiation or chemotherapy with potential for pulmonary toxicity
•3.Prior or planned treatment with interleukin inhibitors or TNF-Î± inhibitors
•4.History of collagen vascular disease
•5.Chronic lung diseases (Chronic obstructive lung disease, bronchial asthma), history of pulmonary tuberculosis
•6.Inability to lie in supine on a flat couch with oxygen supplementation for radiation planning and delivery
•7.Patients with PaO2/FiO2 <100 (severe ARDS) and/or on mechanical ventilation
•8.Patients who are not willing to participate in the study

发起方